Balance Labs Statistics
Total Valuation
Balance Labs has a market cap or net worth of 72.62 million. The enterprise value is 75.19 million.
| Market Cap | 72.62M |
| Enterprise Value | 75.19M |
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Balance Labs has 46.85 million shares outstanding. The number of shares has increased by 18.69% in one year.
| Current Share Class | 46.85M |
| Shares Outstanding | 46.85M |
| Shares Change (YoY) | +18.69% |
| Shares Change (QoQ) | +70.59% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 11.98% |
| Float | 33.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12,103.52 |
| PB Ratio | -21.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.37 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -63.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3,322.38% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 388.16% |
| Weighted Average Cost of Capital (WACC) | 14.15% |
| Revenue Per Employee | 1,500 |
| Profits Per Employee | -7.94M |
| Employee Count | 4 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +746.53% in the last 52 weeks. The beta is 1.78, so Balance Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +746.53% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.33 |
| Average Volume (20 Days) | 1,068 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Balance Labs had revenue of 6,000 and -31.77 million in losses. Loss per share was -1.23.
| Revenue | 6,000 |
| Gross Profit | -12.89M |
| Operating Income | -13.11M |
| Pretax Income | -31.77M |
| Net Income | -31.77M |
| EBITDA | n/a |
| EBIT | -13.11M |
| Loss Per Share | -1.23 |
Balance Sheet
The company has 397,506 in cash and 543,000 in debt, with a net cash position of -145,494 or -0.00 per share.
| Cash & Cash Equivalents | 397,506 |
| Total Debt | 543,000 |
| Net Cash | -145,494 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -3.38M |
| Book Value Per Share | -0.07 |
| Working Capital | -3.38M |
Cash Flow
| Operating Cash Flow | -257,024 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 602,800 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -218,426.78% |
| Pretax Margin | -529,472.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Balance Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.69% |
| Shareholder Yield | -18.69% |
| Earnings Yield | -43.75% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |